Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Biosite Charts. Click Here for more Biosite Charts.](/p.php?pid=staticchart&s=N%5EBSTE&p=8&t=15)
SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE) announces the following webcast:
Biosite Incorporated will announce first quarter 2007 results on Tuesday, April 24, 2007 following the close of the market. The Company will also webcast a conference call on the same day (April 24) at 1:30 p.m. PDT.
What: Biosite's First Quarter Results Conference Call
When: Tuesday, April 24, 2007, at 1:30 p.m. PDT
Where: http://www.videonewswire.com/event.asp?id=38904
OR http://www.biosite.com/
How: Live over the Internet
Telephonic: Dial-In: (617) 213-8832
Passcode: 60807471
You may dial *0 at any time for operator assistance
Contact: Michelle Hickman
Corporate and Investor Relations
Biosite Incorporated
(858) 805-2419
email:
If you are unable to participate during the live webcast, the call will be archived on the Biosite website http://www.biosite.com/ until May 23, 2007. The telephone replay number for U.S. callers is (888) 286-8010 and (617) 801-6888 for international callers, passcode: 50964236.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. The Biosite(R) Triage(R) rapid diagnostic tests are used in approximately 70 percent of U.S. hospitals and in over 60 international markets. Information on Biosite can be found at http://www.biosite.com/.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated.
DATASOURCE: Biosite Incorporated
CONTACT: Michelle Hickman, Corporate & Investor Relations of Biosite
Incorporated, +1-858-805-2419,
Web site: http://www.biosite.com/
Company News On-Call: http://www.prnewswire.com/comp/116737.html